BioInvent International AB (BOVNF) Income Statement
BioInvent International AB Income Statement
Last quarter (Q3 2026), BioInvent International AB's total revenue was $10.79M, an increase of 224.99% from the same quarter last year. In Q3, BioInvent International AB's net income was $-118.91M. See BioInvent International AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 226.50M | $ 44.69M | $ 71.46M | $ 326.13M | $ 19.38M | |
| $ 226.50M | $ 44.69M | $ 71.46M | $ 326.13M | $ 19.38M | |
| $ 578.18M | $ 515.75M | $ 441.40M | $ 376.60M | $ 297.55M | |
| Depreciation and Amortization | $ 19.87M | $ 19.30M | $ 16.75M | $ 14.72M | $ 14.61M |
| $ -331.52M | $ -409.38M | $ -312.71M | $ -27.13M | $ -263.32M | |
| $ -351.39M | $ -471.06M | $ -369.94M | $ -50.92M | $ -278.35M | |
| $ 18.93M | $ 41.82M | $ 39.84M | $ 8.42M | $ -94.00K | |
| $ -332.46M | $ -429.24M | $ -330.10M | $ -42.50M | $ -278.44M | |
| $ -332.86M | $ -429.38M | $ -330.30M | $ -34.09M | $ -278.96M | |
| Per Share Metrics | |||||
| Basic EPS | $ -5.06 | $ -6.53 | $ -5.02 | $ -0.55 | $ -5.15 |
| Diluted EPS | $ -5.06 | $ -6.53 | $ -5.02 | $ -0.55 | $ -5.15 |
| Weighted Average Shares Outstanding | 65.78M | 65.80M | 65.80M | 61.52M | 54.16M |
| Weighted Average Shares Outstanding (Diluted) | 65.78M | 65.80M | 65.80M | 61.52M | 54.16M |
Currency in SEK